GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Quest Diagnostics
Quest Diagnostics, along with Labcorp, is one of two companies that dominate the medical testing market in the US. Its stock price reflects the stable demand for diagnostics, which is the foundation of modern medicine.
Share prices of companies in the market segment - Medanalysis
Quest Diagnostics is one of two dominant players in the clinical laboratory testing market. We classify it as part of the Medanalysis sector. The chart below shows the overall performance of this stable and non-cyclical business, which is an integral part of the healthcare system.
Broad Market Index - GURU.Markets
Quest Diagnostics is a leading provider of clinical laboratory testing services, performing millions of tests for patients and physicians. It is a component of the GURU.Markets index. The chart below represents the market. See how Quest Diagnostics shares compare to the healthcare sector.
Change in the price of a company, segment, and market as a whole per day
DGX - Daily change in the company's share price Quest Diagnostics
Quest Diagnostics is a leading provider of medical diagnostics and laboratory testing services. Its daily share price fluctuations reflect its sensitivity to healthcare trends. This metric is a key component of formulas on System.GURU.Markets, where it is used for in-depth analysis.
Daily change in the price of a set of shares in a market segment - Medanalysis
Quest Diagnostics Incorporated is a leader in the laboratory diagnostics market. This chart shows the average daily volatility of the healthcare sector. Comparing it to DGX's performance helps understand how sensitive its testing-intensive business is to overall trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Quest Diagnostics is one of the world's largest clinical laboratory operators. The healthcare sector is considered relatively defensive. The chart below shows general market fluctuations, which can be used to assess how Quest Diagnostics is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Quest Diagnostics
Quest Diagnostics, along with Labcorp, is a giant in the laboratory diagnostics market. Its annual growth reflects the volume of medical testing nationwide, making it a barometer of the nation's health and the state of the healthcare system.
Annual dynamics of market capitalization of the market segment - Medanalysis
Quest Diagnostics Incorporated is one of the two leaders in the US laboratory diagnostics market. Its business benefits from an aging population and the growth of preventive medicine. The chart below shows how its scale and efficiency allow it to dominate the market and demonstrate stable growth in the healthcare sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Quest Diagnostics, along with Labcorp, is a leader in the clinical laboratory services market. Its business is resilient to economic cycles, as the demand for medical testing is constant. Quest's share price reflects its testing volumes, which can fluctuate depending on the epidemiological situation and new diagnostic technologies.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Quest Diagnostics
Quest Diagnostics, a leader in laboratory testing, shows trends in the healthcare sector. The monthly fluctuations on the chart reflect the volume of tests performed, which are influenced by the number of doctor visits, seasonal illnesses, and changes in health insurance policies.
Monthly dynamics of market capitalization of the market segment - Medanalysis
Quest Diagnostics is one of two giants in the US medical laboratory services market, performing millions of tests daily. The sector's dynamics, shown in the graph, depend on doctor visit volumes and demographic trends. This allows us to assess how Quest's scale and operational efficiency impact its profitability in the face of pricing pressure and competition.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
The medical testing sector is considered defensive because demand for diagnostics is unaffected by the economy. The chart below shows the general market ebbs and flows. Does Quest Diagnostics exhibit this stability, moving more smoothly than the overall market, especially during downturns?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Quest Diagnostics
Quest Diagnostics, a leading provider of diagnostic services and laboratory testing, has a weekly stock price that reflects healthcare trends. The volume of routine medical examinations, seasonal illnesses, and changes in reimbursement policies all contribute to short-term fluctuations.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Quest Diagnostics, a leader in laboratory diagnostics, is a barometer for its healthcare segment. This chart compares the company's stock price with the industry, demonstrating how it is influenced by overall trends in medical testing volumes, which impact all market players.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Quest Diagnostics is a leader in medical laboratory services. Demand for diagnostics is constant, making the business a defensive asset. The chart clearly shows that Quest shares behave like a classic defensive asset, demonstrating stability amid overall market volatility.
Market capitalization of the company, segment and market as a whole
DGX - Market capitalization of the company Quest Diagnostics
Quest Diagnostics' market capitalization is a financial map of the American nation's health. This laboratory giant's chart reflects the volume of medical tests, from routine blood tests to complex diagnostics. Its performance is a barometer of the state of the healthcare system, patient activity, and the implementation of new diagnostic technologies.
DGX - Share of the company's market capitalization Quest Diagnostics within the market segment - Medanalysis
Quest Diagnostics is one of two giants in the US clinical laboratory services market. Its market capitalization reflects its vast network of laboratories and the scale of its testing, which forms the basis for millions of medical diagnoses. The chart clearly shows how much of this vital market Quest controls.
Market capitalization of the market segment - Medanalysis
Quest Diagnostics is one of two giants in the US laboratory diagnostics market. The chart below shows the overall market capitalization of the entire healthcare sector. Its dynamics reflect the aging population and the growing role of diagnostics in modern medicine.
Market capitalization of all companies included in a broad market index - GURU.Markets
Quest Diagnostics is a leader in medical testing, processing millions of tests daily. Its market capitalization chart is a financial reflection of the importance of diagnostics in healthcare. It demonstrates how the data obtained from tests is becoming a key and valuable asset in medicine.
Book value capitalization of the company, segment and market as a whole
DGX - Book value capitalization of the company Quest Diagnostics
Quest Diagnostics is a giant in the medical testing industry. Its book value comes from its vast network of laboratories and testing collection points. The chart below shows how the company is investing in expanding and automating its infrastructure to process millions of tests with high accuracy.
DGX - Share of the company's book capitalization Quest Diagnostics within the market segment - Medanalysis
Quest Diagnostics is a leader in laboratory diagnostics in the United States. Its business is impossible without its vast network of laboratories and thousands of patient service centers. The asset share chart demonstrates the scale of this physical infrastructure, which forms the basis for conducting millions of medical tests.
Market segment balance sheet capitalization - Medanalysis
The healthcare sector, as the graph shows, has a vast material base. Quest Diagnostics, as a diagnostics leader, is a vital part of this. Its business is capital-intensive, requiring a network of hundreds of laboratories and thousands of collection points—the physical infrastructure for testing.
Book value of all companies included in the broad market index - GURU.Markets
Quest Diagnostics is one of the largest players in the US medical testing market. The company's assets include a vast network of laboratories and collection points, which form the foundation for diagnosis. The chart below illustrates the physical scale of this giant within the healthcare infrastructure.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Quest Diagnostics
Quest Diagnostics is one of the two largest companies in the laboratory diagnostics industry. The premium it commands on its assets (laboratories) reflects its scale, its indispensable role in the healthcare system, and its ability to generate stable cash flow.
Market to book capitalization ratio in a market segment - Medanalysis
Quest Diagnostics is a leading provider of medical diagnostics and laboratory testing services. Its value lies in the scale of its laboratory network and the volume of data it generates. This chart shows how investors value its position in the healthcare market beyond the value of its physical equipment.
Market to book capitalization ratio for the market as a whole
Quest Diagnostics is one of the two leaders in the US medical laboratory services market. The company's value lies in its vast network of laboratories and service centers, the scale of its operations, and the accumulated data it has accumulated. This chart shows how the market values this key player in the healthcare system, whose model combines physical infrastructure and expertise.
Debts of the company, segment and market as a whole
DGX - Company debts Quest Diagnostics
Quest Diagnostics, a leader in the medical testing market, uses debt to invest in new testing technologies, lab automation, and strategic acquisitions. Competition and pricing pressure require ongoing investments in efficiency. This chart shows how the company finances its leadership in the diagnostics industry.
Market segment debts - Medanalysis
Quest Diagnostics is one of the two leaders in the US clinical laboratory services market. It is a mature business with stable cash flows. The company's debt policy is typically used to finance acquisitions of smaller laboratories, invest in new equipment, and return capital to shareholders. This chart illustrates Quest's financial strategy in the consolidated healthcare industry.
Market debt in general
Quest Diagnostics Incorporated is a leading provider of medical testing and diagnostic services. This is a relatively stable sector in the healthcare industry. This chart helps understand how Quest is leveraging its financial leverage to invest in new testing technologies and acquire smaller labs to strengthen its extensive service network.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Quest Diagnostics
Quest Diagnostics, a leader in the medical testing market, operates in an industry that requires constant investment in equipment and logistics. This chart shows its financial structure. Debt management is essential for maintaining profitability in the face of pricing pressure from insurance companies and for funding acquisitions of smaller laboratories.
Market segment debt to market segment book capitalization - Medanalysis
Quest Diagnostics is a leading provider of laboratory diagnostic services. This chart shows the debt burden in the medical testing sector. It helps understand how companies in this vital part of healthcare are funding lab automation, network expansion, and the development of new tests to improve disease diagnosis.
Debt to book value of all companies in the market
Quest Diagnostics is a leader in laboratory diagnostics. This chart reflects the overall leverage of corporate America. It allows us to assess how aggressively Quest is using capital for acquisitions and innovation, given the overall economic situation and the availability of financing in the market.
P/E of the company, segment and market as a whole
P/E - Quest Diagnostics
This chart for Quest Diagnostics, a leader in medical laboratory testing, shows its key role in the healthcare system. The company's profits are driven by the volume of tests performed. This metric reflects investor expectations regarding long-term demand for diagnostic services, driven by an aging population and advances in medicine.
P/E of the market segment - Medanalysis
Quest Diagnostics is a leading provider of diagnostic information services. The company's laboratories perform millions of tests annually, helping doctors diagnose and prescribe treatment. This chart illustrates the average value in the medical testing sector, which is characterized by stable demand but also by pricing pressure from insurance companies.
P/E of the market as a whole
Quest Diagnostics is one of the two leaders in the US medical testing market. The company performs billions of tests annually, forming an integral part of the healthcare system. This chart reflects overall market sentiment. Comparisons with it help us understand whether Quest is perceived as a stable, non-cyclical business, or whether its volumes are impacted by factors such as unemployment (and health insurance).
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Quest Diagnostics
Quest Diagnostics is a leading provider of diagnostic information and laboratory testing services in the United States. This chart shows expectations for the healthcare system's development. The assessment depends on the volume of routine and specialized testing, demographic trends, and government reimbursement policies for healthcare services.
%20P%2FE%20Quest%20Diagnostics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Quest-Diagnostics&v=1772581226039 "Chart of the company's future (projected) P/E Quest Diagnostics")
Future (projected) P/E of the market segment - Medanalysis
Quest Diagnostics is a leading provider of diagnostic testing and analysis services in the US. The chart shows how analysts estimate Quest's future profitability relative to the healthcare sector. This provides insight into whether the market views their extensive laboratory network and wide range of tests as a guarantee of sustainable demand and profitability.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772581226073 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Quest Diagnostics is a leader in laboratory diagnostics in the United States. Demand for its services is driven by both routine medical examinations and treatment. This graph of overall market expectations has an indirect impact on Quest. Economic growth impacts employment levels and, consequently, the number of people with health insurance.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772581226133 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Quest Diagnostics
Quest Diagnostics is one of the leading providers of medical testing services in the United States. The company operates a network of laboratories, serving physicians, hospitals, and patients. Its revenue depends on the volume of tests performed, which, in turn, is linked to the overall health of the country. This chart is an indicator of activity in the American medical system.
Profit of companies in the market segment - Medanalysis
Quest Diagnostics is a leader in medical diagnostics and laboratory testing in the United States. Demand for the company's services is fundamental to the healthcare system. This chart illustrates how medical services companies provide a stable and non-cyclical foundation for overall healthcare profitability, growing as the population ages.
Overall market profit
Quest Diagnostics is a leader in medical laboratory testing in the United States. The need for disease diagnostics is constant, providing the company with a stable revenue stream. Quest Diagnostics' business is less susceptible to economic cycles (as seen in this chart) than many other industries, and relies on demographics and medical innovation.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Quest Diagnostics
Quest Diagnostics is one of the two leaders in the US clinical laboratory services market. This chart shows future revenue expectations. Analysts' forecasts depend on the volume of basic diagnostic testing, which correlates with physician visits, as well as the development of more complex and high-margin tests in areas such as genetics and oncology.
%20profit%20of%20the%20company%20Quest%20Diagnostics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Quest-Diagnostics&v=1772581226403 "Graph of future (projected) profit of the company Quest Diagnostics")
Future (predicted) profit of companies in the market segment - Medanalysis
Quest Diagnostics is a leading provider of diagnostic information and laboratory testing services in the United States. This chart shows the revenue forecast for the entire medical diagnostics sector. It reflects expectations for the volume of routine medical examinations and demand for new types of tests. This background is key for assessing Quest Diagnostics' operating capacity and revenue.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772581226475 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Quest Diagnostics is a leader in diagnostic information services. The volume of tests it performs depends on the number of doctor visits and routine medical examinations. Economic downturns, predictable by this schedule, can lead people with limited or no insurance to postpone doctor visits, temporarily reducing testing volumes.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772581226516 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Quest Diagnostics
Quest Diagnostics is one of two dominant companies in the US clinical laboratory testing market. It provides a wide range of tests for physicians, hospitals, and patients. Its revenue depends on testing volumes, which are an integral part of the healthcare system. This chart shows how the market values this stable and scalable business.
P/S market segment - Medanalysis
Quest Diagnostics is a leading provider of diagnostic information services. Its laboratories process millions of tests, from routine blood tests to complex genetic diagnostics. This chart shows the average revenue estimate for the sector, helping to understand how the market views Quest's scale, effectiveness, and key role in the healthcare system.
P/S of the market as a whole
Quest Diagnostics is one of the leading providers of diagnostic testing services in the US. The company operates a network of laboratories and service centers, performing millions of tests annually. It is a vital part of the healthcare system. This overall market valuation chart compares how investors value the stable revenues of the healthcare sector against more cyclical industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Quest Diagnostics
Quest Diagnostics is one of the largest providers of clinical laboratory diagnostic services in the United States. Future revenue depends on the volume of medical tests, which in turn is linked to the total number of doctor visits and screening programs. This graph reflects market expectations based on demographic trends and the development of preventive medicine.
%20P%2FS%20Quest%20Diagnostics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Quest-Diagnostics&v=1772581226712 "The graph of the company's future (projected) P/S Quest Diagnostics")
Future (projected) P/S of the market segment - Medanalysis
Quest Diagnostics is a leading provider of diagnostic testing services in the United States. Laboratory tests are an integral part of modern medicine, ensuring stable demand. This chart shows how the market estimates its future revenue, which benefits from an aging population and the growth of preventive care, despite pricing pressure.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772581226785 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Quest Diagnostics is a leader in diagnostic laboratory services. Demand for its services is largely non-cyclical, as people get sick regardless of the economic situation. However, the general optimism reflected in the chart may influence employers' willingness to include expanded screening programs in insurance and government funding for healthcare.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772581226837 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Quest Diagnostics
Quest Diagnostics is a leading provider of medical diagnostic services. The company's revenue comes from fees for a wide range of laboratory tests for patients, physicians, and hospitals. This chart shows the volume of tests performed, which is influenced by the overall health of the population and trends in preventive medicine.
Sales of companies in the market segment - Medanalysis
Quest Diagnostics is one of the leading providers of diagnostic information services in the United States. The company operates a network of laboratories that perform millions of medical tests for patients, physicians, and hospitals. Revenue is generated from every analysis performed. This graph illustrates the state of the healthcare market, where laboratory diagnostics are a fundamental and integral part of medical care.
Overall market sales
Quest Diagnostics is a leader in medical laboratory testing in the United States. Demand for its services is primarily driven by healthcare needs and is independent of economic cycles. However, employment levels, which correlate with this cycle, impact the number of people with commercial insurance, which affects the volume of routine testing.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Quest Diagnostics
Quest Diagnostics is one of the two leaders in the US clinical laboratory services market (along with Labcorp). The company provides a wide range of tests for patients, physicians, and hospitals. This chart reflects analysts' expectations for routine medical testing volumes, which are driven by the number of physician visits and demographic trends.
%20sales%20of%20the%20company%20Quest%20Diagnostics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Quest-Diagnostics&v=1772581227114 "Schedule of future (projected) sales of the company Quest Diagnostics")
Future (projected) sales of companies in the market segment - Medanalysis
Quest Diagnostics is a leading provider of diagnostic information and laboratory testing services in the United States. The data in the chart shows the outlook for the medical testing sector. This allows us to assess how an aging population, the development of preventive medicine, and laboratory automation are impacting Quest's testing volumes and operational efficiency.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772581227153 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Quest Diagnostics, a leading diagnostic services provider, sees this chart as a reflection of the state of the healthcare system. Rising overall economic forecasts ensure stable funding for medical services and insurance coverage. This allows doctors to order regular and specialized tests, the core of Quest's business.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772581227168 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Quest Diagnostics
Quest Diagnostics is one of the two leaders in the US clinical laboratory testing market (along with Labcorp). They conduct millions of medical tests annually. This chart illustrates how their massive scale and operational efficiency enable the company to achieve stable profitability in a critical yet competitive part of the healthcare system.
Market segment marginality - Medanalysis
Quest Diagnostics is one of the leading providers of diagnostic information services in the United States. The company performs a wide range of laboratory tests for physicians, hospitals, and patients. This chart shows the profitability of its business. Success depends on the scale of operations, laboratory automation, and the ability to offer new, more complex, and higher-margin tests.
Market marginality as a whole
Quest Diagnostics is a leader in the medical testing and laboratory services market. Demand for its services is driven by demographics and healthcare needs, making it relatively non-cyclical. This total market return chart highlights the stability of Quest's business, which is less dependent on economic fluctuations than most other industries.
Employees in the company, segment and market as a whole
Number of employees in the company Quest Diagnostics
Quest Diagnostics is a leading provider of diagnostic information services. This chart directly reflects the volume of medical tests performed. The growth in the number of lab technicians, couriers, and customer service specialists is a result of the aging population, the availability of new tests, and the overall increased focus on preventative medicine.
Share of the company's employees Quest Diagnostics within the market segment - Medanalysis
Quest Diagnostics is one of the leading providers of diagnostic information and laboratory testing services in the US. This chart shows the company's workforce in the healthcare sector. It reflects the vast number of lab technicians and medical professionals Quest brings together to perform millions of tests critical to diagnosis.
Number of employees in the market segment - Medanalysis
Quest Diagnostics is one of the leading providers of diagnostic testing and analysis services in the United States. This chart illustrates the enormous employment scale of the medical laboratory sector. Tens of thousands of lab technicians, phlebotomists, and logisticians form the backbone of a national network that processes millions of tests daily, playing a critical role in the healthcare system.
Number of employees in the market as a whole
Quest Diagnostics is a leader in laboratory diagnostics. They perform millions of tests daily, helping doctors make diagnoses. This total employment chart reflects the number of people covered by health insurance. The growth in the number of employees with corporate insurance directly translates into an increase in the number of routine and diagnostic tests performed in Quest's laboratories.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Quest Diagnostics (DGX)
Quest Diagnostics is a leading provider of diagnostic information services. This chart shows a business that combines large-scale operations and technology. The moderate cost per employee reflects both the large number of lab technicians and couriers, as well as automated labs processing millions of tests per day.
%20of%20the%20company%20Quest%20Diagnostics%20(DGX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Quest-Diagnostics-DGX&v=1772581227546 "Chart of market capitalization per employee (in thousands of dollars) of the company Quest Diagnostics (DGX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Quest Diagnostics (DGX) is one of two dominant companies in the laboratory testing industry. It's a high-volume service business, requiring a network of laboratories and a large staff of technicians. This chart shows the market price per employee in this high-volume medical industry.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772581227564 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Quest Diagnostics is a leader in laboratory diagnostics, offering a wide range of tests and analyses. Its business is built on scale and efficiency. This chart shows the market value each employee generates by processing millions of tests per day. This is a measure of productivity in this important healthcare sector.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772581227594 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Quest Diagnostics (DGX)
Quest Diagnostics is the other half of the "duopoly" in the US clinical testing market. Their business is highly automated labs. This chart shows how efficiently they process millions of tests. It measures the net profit generated by each lab or collection site employee. This is a direct indicator of their operational efficiency and automation.
%20Chart%20Quest%20Diagnostics%20(DGX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Quest-Diagnostics-DGX&v=1772581227624 "Company Profit Per Employee (in thousands of dollars) Chart Quest Diagnostics (DGX)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Quest Diagnostics (DGX) is one of two giants (along with Labcorp) in the laboratory diagnostics (testing) space. This chart shows the benchmark for Medanalysis (Diagnostics). In this sector, staff profitability is an indicator of automation. It's a "test factory." The benchmark shows how efficiently the sector processes millions of test tubes.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772581227656 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Quest Diagnostics is a leader in diagnostic information services, operating a network of laboratories across the country. It's a high-volume business where accuracy and efficiency are paramount. This chart shows how automation and scale enable the company to process millions of tests and generate stable profits at a relatively low cost per service.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772581227701 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Quest Diagnostics (DGX)
Quest Diagnostics is a leading provider of diagnostic information and laboratory testing services. This chart shows its performance in the healthcare sector. The increase in revenue per employee reflects increased testing volumes, automated lab processes, and the company's ability to effectively collaborate with physicians and hospitals across the country.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Quest-Diagnostics-DGX&v=1772581227761 "Sales chart per company employee Quest Diagnostics (DGX)")
Sales per employee in the market segment - Medanalysis
Quest Diagnostics (DGX) is one of the two dominant companies in the US clinical laboratory testing market (along with Labcorp). It's a labor-intensive business, requiring a network of laboratories and technicians. This chart shows the industry average revenue per employee, helping to assess the productivity of their extensive laboratory network.
Sales per employee for the market as a whole
Quest Diagnostics is one of two giants in the laboratory diagnostics industry (along with Labcorp). They perform billions of tests for doctors and hospitals. This business is built on scale and automation. This chart shows how efficiently their highly automated labs generate revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Quest Diagnostics (DGX)
Quest Diagnostics is one of the two dominant lab testing companies in the US. This chart shows bearish bets. Shorts against DGX, like those against Labcorp, are driven by a sharp decline in COVID testing revenue and pressure from insurance companies, which are reducing reimbursements for routine testing, putting pressure on profitability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Quest-Diagnostics-DGX&v=1772581227975 "Short Shares Chart for the Company Quest Diagnostics (DGX)")
Shares shorted by market segment - Medanalysis
Quest Diagnostics (DGX) is one of two giants in the US clinical laboratory services market. This chart shows bets against the healthcare sector. The rising "bet against" the industry may reflect investor concerns about declining routine testing volumes (due to the recession) or pressure from insurance companies on test pricing, which is putting pressure on DGX's margins.
Shares shorted by the overall market
Quest Diagnostics, like Labcorp, is a leader in the medical testing market. It's a defensive sector, but not completely isolated from the economy. This indicator of general market fear is important. If investor pessimism escalates into a real recession, people may undergo fewer routine checkups and companies may cut back on their corporate wellness programs, which impacts Quest's testing volumes.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Quest Diagnostics (DGX)
Quest Diagnostics is one of two giants in the clinical testing market. Their business is driven by the volume of tests ordered by doctors. This oscillator measures momentum. A severe flu season or the launch of a new popular test (for example, in oncology) could trigger a rally (above 70). Meanwhile, news of Medicare rate cuts (putting downward pressure on prices) would push it below 30.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Quest-Diagnostics-DGX&v=1772581228092 "RSI 14 indicator chart for the company's stock Quest Diagnostics (DGX)")
RSI 14 Market Segment - Medanalysis
Quest Diagnostics is one of the leading providers of clinical laboratory diagnostics services in the United States. They perform a wide range of tests for physicians, hospitals, and patients, playing a key role in healthcare. This metric reflects the overall health of the medical diagnostics industry, helping determine whether the entire sector is oversold after the pandemic's peak or is stable.
RSI 14 for the overall market
Quest Diagnostics (DGX) is a leading provider of diagnostic services and laboratory testing in the US. It is an important and stable part of the healthcare sector. This indicator reflects general market panic or euphoria. In times of panic, investors often seek safe havens, and DGX shares, with their robust demand for testing, may be one such haven.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast DGX (Quest Diagnostics)
Quest Diagnostics is, along with Labcorp, one of the two dominant players in the US laboratory diagnostics market. This chart reflects analyst forecasts for basic medical testing volumes (which are recovering from the pandemic) and pricing pressure from insurance companies, which is impacting reimbursement.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-DGX-Quest-Diagnostics&v=1772581228212 "A chart showing analyst consensus forecasts for the expected stock price. DGX (Quest Diagnostics)")
The difference between the consensus estimate and the actual stock price DGX (Quest Diagnostics)
Quest Diagnostics, along with Labcorp, is the dominant player in the US medical testing market. They operate thousands of labs and patient service centers. Their business is built on scale and efficiency. This chart shows analysts' estimates of routine testing volumes and demand for new (genetic) tests. It reflects the gap between the target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-DGX-Quest-Diagnostics&v=1772581228246 "A chart showing the difference between the consensus forecast and the actual stock price. DGX (Quest Diagnostics)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Quest Diagnostics is one of two giants (along with Labcorp) in the US medical testing and laboratory services market. This chart shows analysts' overall expectations for the medical testing sector. It reflects whether experts expect demand for routine diagnostics to grow or decline following the pandemic boom.
Analysts' consensus forecast for the overall market share price
Quest Diagnostics (DGX) is one of two giants in the US laboratory diagnostics market (along with Labcorp). Millions of samples pass through their labs daily, providing physicians with critical information. This chart shows the overall market sentiment, reflecting analysts' confidence in the stability of routine healthcare spending.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Quest Diagnostics
Quest Diagnostics is one of the two pillars (along with Labcorp) of the US laboratory diagnostics market. They are a critical yet low-margin component of the healthcare system, performing billions of tests. This chart is a barometer of healthcare system utilization. Barring spikes (like COVID-19), its dynamics reflect a steady, demographically driven growth in demand for medical tests.
AKIMA Market Segment Index - Medanalysis
Quest Diagnostics (DGX) is one of two (along with Labcorp) giants in the laboratory diagnostics industry in the US; the company operates an invisible network of laboratories, processing millions of tests (blood, etc.). This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how does Quest's large and indispensable role in healthcare differentiate it from the average competitor?
The AKIM Index for the overall market
Quest Diagnostics is one of two giants (along with Labcorp) in the clinical laboratory testing industry. It's a low-margin, high-volume business. This chart, reflecting the market average, provides context. It helps us assess how Quest, a protective business dependent on the volume of routine medical exams, fits into the overall macroeconomic picture.
